Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions. | Oncogenesis | 2023 | 37666817 | PubTator, text mining | PubMed |
| Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer. | Front Oncol | 2023 | 37664033 | PubTator, text mining | PubMed |
| Epigenetic control of pancreatic cancer metastasis. | Cancer Metastasis Rev | 2023 | 37659057 | PubTator, text mining | PubMed |
| The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop. | Virchows Arch | 2023 | 37656249 | PubTator, text mining | PubMed |
| Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets. | Clin Cancer Res | 2023 | 37643132 | PubTator, text mining | PubMed |
| New twists of a TAIL: novel insights into the histone binding properties of a highly conserved PHD finger cluster within the MLR family of H3K4 mono-methyltransferases. | Nucleic Acids Res | 2023 | 37638761 | PubTator, text mining | PubMed |
| HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers. | Nucleic Acids Res | 2023 | 37638746 | PubTator, text mining | PubMed |
| Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer. | iScience | 2023 | 37636034 | PubTator, text mining | PubMed |
| Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets. | Leukemia | 2023 | 37634012 | PubTator, text mining | PubMed |
| Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers. | Int J Mol Sci | 2023 | 37628978 | PubTator, text mining | PubMed |
| Absence of Lugol staining indicates initiation of esophageal squamous cell carcinoma: A combined genomic and epidemiologic study. | Cell Rep Med | 2023 | 37625408 | PubTator, text mining | PubMed |
| Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy. | Discov Oncol | 2023 | 37624511 | PubTator, text mining | PubMed |
| An Overview of Pancreatic Neuroendocrine Tumors and an Update on Endoscopic Techniques for Their Management. | Curr Oncol | 2023 | 37623030 | PubTator, text mining | PubMed |
| Methylation across the central dogma in health and diseases: new therapeutic strategies. | Signal Transduct Target Ther | 2023 | 37620312 | PubTator, text mining | PubMed |
| HOXC13 promotes cell proliferation, metastasis and glycolysis in breast cancer by regulating DNMT3A. | Exp Ther Med | 2023 | 37614427 | PubTator, text mining | PubMed |
| Convergent somatic evolution commences in utero in a germline ribosomopathy. | Nat Commun | 2023 | 37608017 | PubTator, text mining | PubMed |
| Demethylase-independent roles of LSD1 in regulating enhancers and cell fate transition. | Nat Commun | 2023 | 37607921 | PubTator, text mining | PubMed |
| Species-specific roles for the MAFA and MAFB transcription factors in regulating islet β cell identity. | JCI Insight | 2023 | 37606041 | PubTator, text mining | PubMed |
| Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer. | Sci Rep | 2023 | 37604837 | PubTator, text mining | PubMed |
| PTPRD mutation is a prognostic biomarker for sensitivity to ICIs treatment in advanced non-small cell lung cancer. | Aging (Albany NY) | 2023 | 37602864 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=24